share_log

Vertex Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Tatsis Ourania

Vertex Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Tatsis Ourania

福泰制药 | 4：持股变动声明-高管 Tatsis Ourania
美股sec公告 ·  06/03 16:12
Moomoo AI 已提取核心信息
Ourania Tatsis, EVP, Chief Regulatory & Quality Officer at Vertex Pharmaceuticals Inc. (VRTX), completed the sale of company shares on two separate occasions. On May 30, 2024, Tatsis sold 2,350 shares of common stock at a price of $439.11 per share. The following day, on May 31, 2024, an additional 2,250 shares were sold at $445.00 per share. The total number of shares disposed of across both transactions was 4,600, resulting in a combined market value of $2,033,158.50. After these transactions, Tatsis directly holds 51,273 shares of Vertex Pharmaceuticals.
Ourania Tatsis, EVP, Chief Regulatory & Quality Officer at Vertex Pharmaceuticals Inc. (VRTX), completed the sale of company shares on two separate occasions. On May 30, 2024, Tatsis sold 2,350 shares of common stock at a price of $439.11 per share. The following day, on May 31, 2024, an additional 2,250 shares were sold at $445.00 per share. The total number of shares disposed of across both transactions was 4,600, resulting in a combined market value of $2,033,158.50. After these transactions, Tatsis directly holds 51,273 shares of Vertex Pharmaceuticals.
福泰制药公司的执行副总裁、首席监管与质量官Ourania Tatsis在两次不同的情况下出售了公司股份。2024年5月30日，Tatsis以每股439.11美元的价格出售了2,350股普通股。次日，即2024年5月31日，又以445.00美元的价格出售了另外2,250股股票。这两次交易中出售的股票总数为4,600股，合并市值为2,033,158.50美元。在这些交易之后，Tatsis直接持有Vertex Pharmaceuticals公司的51,273股股份。
福泰制药公司的执行副总裁、首席监管与质量官Ourania Tatsis在两次不同的情况下出售了公司股份。2024年5月30日，Tatsis以每股439.11美元的价格出售了2,350股普通股。次日，即2024年5月31日，又以445.00美元的价格出售了另外2,250股股票。这两次交易中出售的股票总数为4,600股，合并市值为2,033,158.50美元。在这些交易之后，Tatsis直接持有Vertex Pharmaceuticals公司的51,273股股份。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息